These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15815016)

  • 21. Genetic characterization of hypervariable region 1 in patients chronically infected with hepatitis C virus genotype 2.
    Fan X; Di Bisceglie AM
    J Med Virol; 2001 Jul; 64(3):325-33. PubMed ID: 11424122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constrained genomic and conformational variability of the hypervariable region 1 of hepatitis C virus in chronically infected patients.
    Hino K; Korenaga M; Orito E; Katoh Y; Yamaguchi Y; Ren F; Kitase A; Satoh Y; Fujiwara D; Okita K
    J Viral Hepat; 2002 May; 9(3):194-201. PubMed ID: 12010507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection.
    Kato N; Ootsuyama Y; Sekiya H; Ohkoshi S; Nakazawa T; Hijikata M; Shimotohno K
    J Virol; 1994 Aug; 68(8):4776-84. PubMed ID: 7518526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a hepatitis C virus genotype 1 divergent isolate from an HIV-1 coinfected individual in Germany assigned to a new subtype 1o.
    Wang B; Krüger L; Machnowska P; Eshetu A; Gunsenheimer-Bartmeyer B; Bremer V; Hauser A; Bannert N; Bock CT
    Virol J; 2019 Mar; 16(1):28. PubMed ID: 30832687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variability of the envelope regions of HCV in European isolates and its significance for diagnostic tools.
    Roggendorf M; Lu M; Fuchs K; Ernst G; Höhne M; Schreier E
    Arch Virol Suppl; 1993; 7():27-39. PubMed ID: 8219809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness and limitation of phylogenetic analysis for hepatitis C virus core region: application to isolates from Egyptian and Yemeni patients.
    Ohno T; Mizokami M; Saleh MG; Orito E; Ohba KI; Wu RR; Koide T; Tibbs CJ; Nouri-Aria KT; Tokudome S; Williams R
    Arch Virol; 1996; 141(6):1101-13. PubMed ID: 8712927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative rates of nucleotide sequence variation in the hypervariable region of E1/E2 and the NS5b region of hepatitis C virus in patients with a spectrum of liver disease resulting from a common source of infection.
    Duffy M; Salemi M; Sheehy N; Vandamme AM; Hegarty J; Curry M; Nolan N; Kelleher D; McKiernan S; Hall WW
    Virology; 2002 Sep; 301(2):354-64. PubMed ID: 12359437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morocco underwent a drift of circulating hepatitis C virus subtypes in recent decades.
    Brahim I; Akil A; Mtairag el M; Pouillot R; Malki AE; Nadir S; Alaoui R; Njouom R; Pineau P; Ezzikouri S; Benjelloun S
    Arch Virol; 2012 Mar; 157(3):515-20. PubMed ID: 22160625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular heterogeneity and new subtypes of HCV genotype 4.
    Rapicetta M; Argentini C; Dettori S; Spada E; Pellizzer G; Gandin C
    Res Virol; 1998; 149(5):293-7. PubMed ID: 9879607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NS5A sequence heterogeneity of hepatitis C virus genotype 4a predicts clinical outcome of pegylated-interferon-ribavirin therapy in Egyptian patients.
    El-Shamy A; Shoji I; El-Akel W; Bilasy SE; Deng L; El-Raziky M; Jiang DP; Esmat G; Hotta H
    J Clin Microbiol; 2012 Dec; 50(12):3886-92. PubMed ID: 22993188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular epidemiology of hepatitis C infections in Ningxia, China: genotype, phylogeny and mutation analysis.
    Wu Z; Cui L; Zhao W; Yang D; Chen H; Wang R; Wang X; Zhang L; He T
    Virol J; 2016 Oct; 13(1):172. PubMed ID: 27756381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus subtyping based on sequencing of the C/E1 and NS5B genomic regions in comparison to a commercially available line probe assay.
    Avó AP; Agua-Doce I; Andrade A; Pádua E
    J Med Virol; 2013 May; 85(5):815-22. PubMed ID: 23508907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A correlation between the heterogeneity of hypervariable region 1 of E2 glycoprotein of Hepatitis C virus (HCV) and HCV antibody profile: a case study.
    Kmieciak D; Biernacka-Lukanty J; Migdalski P; Turek-Plewa J; Wierzbicki A; Juszczyk J; Trzeciak WH
    Acta Virol; 2005; 49(2):97-103. PubMed ID: 16047736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analysis of amino acid sequences from envelope proteins isolated from different hepatitis C virus variants: possible role of conservative and variable regions.
    Sobolev BN; Poroikov VV; Olenina LV; Kolesanova EF; Archakov AI
    J Viral Hepat; 2000 Sep; 7(5):368-74. PubMed ID: 10971825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization.
    Blackard JT; Ma G; Welge JA; Martin CM; Sherman KE; Taylor LE; Mayer KH; Jamieson DJ
    J Med Virol; 2012 Feb; 84(2):242-52. PubMed ID: 22170544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins.
    Weiner AJ; Brauer MJ; Rosenblatt J; Richman KH; Tung J; Crawford K; Bonino F; Saracco G; Choo QL; Houghton M
    Virology; 1991 Feb; 180(2):842-8. PubMed ID: 1846505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variations in the hypervariable region 1 of the envelope region E2 of hepatitis C virus RNA appear associated with virus persistence independently of liver disease.
    Brunetto MR; Suzuki T; Aizaky H; Flichman D; Colombatto P; Abate ML; Oliveri F; Matsuura Y; Bonino F; Miyamura T
    Ital J Gastroenterol; 1996 Dec; 28(9):499-504. PubMed ID: 9131394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivity.
    Prentoe J; Velázquez-Moctezuma R; Foung SK; Law M; Bukh J
    Hepatology; 2016 Dec; 64(6):1881-1892. PubMed ID: 27351277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Migration patterns of hepatitis C virus in China characterized for five major subtypes based on samples from 411 volunteer blood donors from 17 provinces and municipalities.
    Lu L; Wang M; Xia W; Tian L; Xu R; Li C; Wang J; Rong X; Xiong H; Huang K; Huang J; Nakano T; Bennett P; Zhang Y; Zhang L; Fu Y
    J Virol; 2014 Jul; 88(13):7120-9. PubMed ID: 24719413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.